Hedge Funds Are Buying Amgen, Inc. (AMGN)
To the average investor, there are tons of metrics shareholders can use to analyze stocks. Some of the most innovative are hedge fund and insider trading activity.
Hedge Fund - OrbiMed Advisors
News, Interviews, and Investor Letters
- First
- << Previous
- 71 - 76
This Metric Says You Are Smart to Buy Merck & Co., Inc. (MRK)
Now, according to many investors, hedge funds are viewed as delayed, old investment tools of a period lost to current times.
Orbimed Advisors Takes a Major Stake in Ambit Biosciences Corp (AMBI)
In the smart money’s world, Samuel Isaly’s Orbimed Advisors reported a purchase of some 2.1 million shares of Ambit Biosciences Corp (NASDAQ:AMBI) in a 13D filing with the SEC’s Edgar system.
Healthcare Investor Sam Isaly’s Top Stock Picks Include Pfizer
Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets.
Why is Orbimed Backing Out of Amarin?
Orbimed Advisors, managed by Samuel Isaly, is a hedge fund with a focus on the healthcare sector.
Hedge Fund News: Paul Tudor Jones, Randy Smith, OrbiMed
The European arm of the Tudor Group, the US hedge fund founded by Paul Tudor Jones II, paid its staff a bumper $62m last year after a profitable 2011, despite the travails of the eurozone.
- First
- << Previous
- 71 - 76